2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O9] Oral Session 9　Genitourinary Cancer
【E】

Fri. Feb 18, 2022 8:20 AM - 9:50 AM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Keita Uchino（Department of Medical Oncology, NTT Medical Center Tokyo），Nobuaki Matsubara（Department of Medical Oncology, National Cancer Center Hospital East）
Discussant：Ken-ichi Tabata（Department of Urology, Kitasato University School of Medicine）

[O9-4] Upfront abiraterone acetate for high-risk metastatic hormone-sensitive prostate cancer

○Kazutoshi Fujita1, Naoki Matsumura2, Nishimoto Mitsuhisa1, Yutaka Yamamoto3, Ken Kuwahara4, Yasuharu Nagai5, Takafumi Minami1, Yuji Hatanaka6, Masahiro Nozawa1, Yasuhiro Morimoto7, Hideo Tahara2, Shigeya Uejima5, Atsunobu Esa4, Akihide Hirayama3, Kazuhiro Yoshimura1, Hirotsugu Uemura1 (1.Department of Urology, Kindai University Faculty of Medicine, 2.Department of Urology, Mimihara General Hospital, 3.Department of Urology, Faculty of Medicine, Kindai University Nara Hospital,, 4.Department of Urology, Kaizuka City Hospital, 5.Department of Urology, National Hospital Organization Osaka Minami Medical Center,, 6.Department of Urology, Saiseikai Tondabayashi Hospital,, 7.Morimoto Urological Clinic)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password